• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认知功能在 IDH1 野生型和 MGMT 未甲基化的高级别胶质瘤患者中有预后价值。

Cognitive functioning is prognostic in patients with IDH1-wild type and MGMT-unmethylated high-grade gliomas.

机构信息

Uroš Smrdel, Institute of Oncology Ljubljana, Zaloška 2, 1000 Ljubljana, Slovenia,

出版信息

Croat Med J. 2023 Dec 31;64(6):383-390. doi: 10.3325/cmj.2023.64.383.

DOI:10.3325/cmj.2023.64.383
PMID:38168519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10797236/
Abstract

AIM

To investigate the prognostic factors of survival in patients with high-grade gliomas without isocitrate dehydrogenase-1 (IDH) mutation and O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation.

METHODS

The study enrolled Slovenian patients with high-grade gliomas. Postoperatively, they completed a battery of neuropsychological tests. Demographics and clinical data were collected. The results of cognitive tests were converted to standardized scores and dichotomized based on impairment. A univariate Cox proportional hazard regression model was used to determine clinical predictors, and a multivariate Cox model was used to determine the prognostic value of cognitive test results. Kaplan-Meier curves were constructed, and survival was compared with the log rank test.

RESULTS

The study enrolled 49 patients with IDH wild-type, MGMT-unmethylated high-grade gliomas. The median time to progression was 9.92 months (7.25, 12.59) and the overall median survival was 12.19 months (8.95, 15.4). Age and the extent of surgery were significant prognostic factors for survival. After controlling for these factors, cognitive functioning in the domain of verbal fluency remained a significant predictor of survival outcomes.

CONCLUSION

Cognitive functioning in the domain of verbal fluency was associated with overall survival independently of age and the extent of surgery. Cognitive functioning could be an important stratifying tool in this group of patients lacking other predictors.

摘要

目的

研究 IDH 突变和 O6-甲基鸟嘌呤-DNA 甲基转移酶(MGMT)启动子甲基化阴性的高级别胶质瘤患者的生存预后因素。

方法

本研究纳入了斯洛文尼亚的高级别胶质瘤患者。术后,他们完成了一系列神经心理学测试。收集了人口统计学和临床数据。将认知测试的结果转换为标准分数,并根据损伤进行二分。采用单变量 Cox 比例风险回归模型确定临床预测因素,采用多变量 Cox 模型确定认知测试结果的预后价值。构建 Kaplan-Meier 曲线,并通过对数秩检验比较生存情况。

结果

本研究纳入了 49 例 IDH 野生型、MGMT 未甲基化的高级别胶质瘤患者。无进展生存期的中位数为 9.92 个月(7.25,12.59),总生存期的中位数为 12.19 个月(8.95,15.4)。年龄和手术范围是生存的显著预后因素。在控制这些因素后,言语流畅性领域的认知功能仍然是生存结局的显著预测因素。

结论

言语流畅性领域的认知功能与总生存期独立相关,与年龄和手术范围无关。在这群缺乏其他预测因素的患者中,认知功能可能是一个重要的分层工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/f1d23b7faf94/CroatMedJ_64_0383-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/c1e73f655366/CroatMedJ_64_0383-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/e17f11b4e512/CroatMedJ_64_0383-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/da4dbb97f1fc/CroatMedJ_64_0383-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/f1d23b7faf94/CroatMedJ_64_0383-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/c1e73f655366/CroatMedJ_64_0383-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/e17f11b4e512/CroatMedJ_64_0383-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/da4dbb97f1fc/CroatMedJ_64_0383-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc33/10797236/f1d23b7faf94/CroatMedJ_64_0383-F4.jpg

相似文献

1
Cognitive functioning is prognostic in patients with IDH1-wild type and MGMT-unmethylated high-grade gliomas.认知功能在 IDH1 野生型和 MGMT 未甲基化的高级别胶质瘤患者中有预后价值。
Croat Med J. 2023 Dec 31;64(6):383-390. doi: 10.3325/cmj.2023.64.383.
2
Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients.IDH1、O6-甲基鸟嘌呤-DNA 甲基转移酶启动子甲基化和 1p19q 共缺失在日本恶性胶质瘤患者中的预后价值。
World J Surg Oncol. 2013 Oct 25;11:284. doi: 10.1186/1477-7819-11-284.
3
Incidence of biomarkers in high-grade gliomas and their impact on survival in a diverse SouthEast Asian cohort - a population-based study.东南亚不同人群中高级别胶质瘤的生物标志物发生率及其对生存的影响:一项基于人群的研究。
BMC Cancer. 2020 Jan 31;20(1):79. doi: 10.1186/s12885-020-6536-x.
4
Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.端粒酶逆转录酶(TERT)启动子突变对弥漫性胶质瘤中异柠檬酸脱氢酶(IDH)突变和O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化的临床意义
Pathol Res Pract. 2018 Jun;214(6):881-888. doi: 10.1016/j.prp.2018.04.002. Epub 2018 Apr 5.
5
IDH1/2 Mutation and MGMT Promoter Methylation - the Relevant Survival Predictors in Czech Patients with Brain Gliomas.异柠檬酸脱氢酶1/2突变与O6-甲基鸟嘌呤-DNA甲基转移酶启动子甲基化——捷克脑胶质瘤患者的相关生存预测指标
Folia Biol (Praha). 2016;62(5):194-202. doi: 10.14712/fb2016062050194.
6
The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.MGMT甲基化和IDH-1突变对接受放化疗的胶质母细胞瘤长期预后的影响。
Acta Neurochir (Wien). 2016 Oct;158(10):1943-53. doi: 10.1007/s00701-016-2928-8. Epub 2016 Aug 15.
7
The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas.IDH 突变和 MGMT 启动子状态在二级高级别胶质瘤中的预后价值。
J Neurooncol. 2012 Dec;110(3):325-33. doi: 10.1007/s11060-012-0977-2. Epub 2012 Sep 27.
8
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.在经标准放化疗治疗的异柠檬酸脱氢酶1(IDH1)野生型原发性胶质母细胞瘤中,人端粒酶逆转录酶(TERT)启动子突变可使甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化带来生存优势。
Neuro Oncol. 2017 Mar 1;19(3):394-404. doi: 10.1093/neuonc/now189.
9
The association between C-methionine uptake, IDH gene mutation, and MGMT promoter methylation in patients with grade II and III gliomas.II级和III级神经胶质瘤患者中碳-蛋氨酸摄取、异柠檬酸脱氢酶(IDH)基因突变与O6-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化之间的关联。
Clin Radiol. 2020 Aug;75(8):622-628. doi: 10.1016/j.crad.2020.03.033. Epub 2020 Apr 19.
10
Clinicopathological Features and Prognosis of Indonesian Patients with Gliomas with IDH Mutation: Insights into Its Significance in a Southeast Asian Population.具有 IDH 突变的印尼胶质瘤患者的临床病理特征和预后:对其在东南亚人群中的意义的深入了解。
Asian Pac J Cancer Prev. 2020 Aug 1;21(8):2287-2295. doi: 10.31557/APJCP.2020.21.8.2287.

引用本文的文献

1
Mechanism analysis and targeted therapy of IDH gene mutation in glioma.胶质瘤中异柠檬酸脱氢酶(IDH)基因突变的机制分析与靶向治疗
Am J Cancer Res. 2025 Jan 15;15(1):248-270. doi: 10.62347/NSXC2205. eCollection 2025.

本文引用的文献

1
MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme.MGMT 和全基因组 DNA 甲基化对多形性胶质母细胞瘤的诊断、预后和治疗的影响。
Int J Mol Sci. 2022 Jun 27;23(13):7148. doi: 10.3390/ijms23137148.
2
Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States.分子生物标志物定义的脑肿瘤:美国的流行病学、有效性和完整性。
Neuro Oncol. 2022 Nov 2;24(11):1989-2000. doi: 10.1093/neuonc/noac113.
3
Frailty in Glioblastoma Is Independent From Chronological Age.
胶质母细胞瘤中的衰弱与实际年龄无关。
Front Neurol. 2021 Nov 30;12:777120. doi: 10.3389/fneur.2021.777120. eCollection 2021.
4
Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival.老年(65 岁以上)新发胶质母细胞瘤患者:患者虚弱、合并症负担和肥胖对总生存期的影响。
J Neurooncol. 2020 Sep;149(3):421-427. doi: 10.1007/s11060-020-03625-2. Epub 2020 Sep 29.
5
Clinical Significance of Various Classification Standards of Age Groups in Predicting Survival of Patients with Glioblastoma.不同年龄段分组标准对预测胶质母细胞瘤患者生存的临床意义。
Med Sci Monit. 2020 May 30;26:e920627. doi: 10.12659/MSM.920627.
6
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.成人脑胶质母细胞瘤:神经肿瘤学会(SNO)和欧洲神经肿瘤学会(EANO)关于当前管理和未来方向的共识综述。
Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106.
7
Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study.清醒开颅手术治疗脑胶质瘤患者的神经认知变化:一项回顾性队列研究。
J Neurooncol. 2020 Jan;146(1):97-109. doi: 10.1007/s11060-019-03341-6. Epub 2019 Dec 4.
8
Early cognitive function tests predict early progression in glioblastoma.早期认知功能测试可预测胶质母细胞瘤的早期进展。
Neurooncol Pract. 2015 Sep;2(3):137-143. doi: 10.1093/nop/npv007. Epub 2015 May 12.
9
The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma.新诊断为胶质母细胞瘤患者的生活质量和神经认知的变化过程。
Radiother Oncol. 2017 Nov;125(2):228-233. doi: 10.1016/j.radonc.2017.07.027. Epub 2017 Aug 8.
10
The effect of IDH1 mutation on the structural connectome in malignant astrocytoma.异柠檬酸脱氢酶1(IDH1)突变对恶性星形细胞瘤结构连接组的影响。
J Neurooncol. 2017 Feb;131(3):565-574. doi: 10.1007/s11060-016-2328-1. Epub 2016 Nov 15.